Withania somnifera Root Extract Enhances Chemotherapy through ‘Priming’

Withania somnifera extracts are known for their anti-cancerous, anti-inflammatory and antioxidative properties. One of their mechanisms of actions is to modulate mitochondrial function through increasing oxidative stress. Recently ‘priming’ has been suggested as a potential mechanism for enhancing cancer cell death. In this study we demonstrate that ‘priming’, in HT-29 colon cells, with W. somnifera root extract increased the potency of the chemotherapeutic agent cisplatin. We have also showed the W. somnifera root extract enhanced mitochondrial dysfunction and that the underlying mechanism of ‘priming’ was selectively through increased ROS. Moreover, we showed that this effect was not seen in non-cancerous cells

The effect of injectable calcium phosphate cement on bone anchorage of titanium implants: an experimental feasibility study in dogs

Calcium phosphate has high osteotransductive potential. The injectable form of calcium phosphate cement (ICAP) can be used as an adjunctive supportive agent for dental implants. The aim of this study was to assess the effect of an ICAP on the reverse torque resistance of titanium implants. Two implant beds (total 24) were prepared in each proximal tibia of 6 beagles. ICAP was injected into one of prepared implant beds (test) and the implant was inserted. The next implant was inserted without ICAP to serve as control. Three dogs were killed after 2 weeks and 3 after 12 weeks. Retrieved implants were subjected to reverse torque test. Results were analyzed with Student's t-test. Scanning electron microscope (SEM) was used for further evaluation. Mean torque values in 2-week healed implants were 52.48 N cm and 50.57 N cm for test and control implants, respectively (p = 0.4). 12-week healed implants showed 81.61 N cm and 76.71 N cm for test and control implants, respectively (p = 0.14). Results indicated no statistical difference between test and control implants for either healing time. SEM images of tested samples revealed close contact between the bone ICAP titanium surface. ICAP must be tested on further developed experimental models

Oxytocin‐loaded sustained‐release hydrogel graft provides accelerated bone formation: An experimental rat study

Restoration of the lost bone volume is one of the most deliberate issues in dentistry. Sustained-release microspherical oxytocin hormone in a poloxamer hydrogel scaffold combined with a mixture of beta-tricalcium phosphate and hydroxyapatite (CP) may serve as a suitable bone graft. The aim of this study was to design and test a novel thermosensitive hydrogel graft incorporating oxytocin-loaded poly(d, l-lactide-co-glycolide) (PLGA) sustained-release microspheres and CP. Thermosensitive poloxamer hydrogel containing CP (HCP graft) was prepared as a base and combined with hollow microspheres (HCPM) and oxytocin-loaded microspheres (HCPOM). Eighty Wistar rats were used for testing the grafts and a control group in 8-mm-diameter critical-sized calvarial defects (CSD); (n = 20). Bone healing at the 4th and 8th weeks was evaluated by histological, histomorphometric, and radiological (micro-computed tomography [mu CT]) analyses. The results were analyzed by two-way analysis of variance (P .05). mu CT findings of HCPOM group showed the highest mean bone mineral density values (42.21 +/- 5.14 and 46.94 +/- 3.30 g/cm(3) for the 4th and 8th weeks, respectively; P < .0027). The proposed oxytocin-loaded sustained-release PLGA microspheres containing thermosensitive hydrogel graft (HCPOM) provide an accelerated bone regeneration in the rat calvaria

Injectable Calcium Phosphate Cement as a Bone-Graft Material Around Peri-implant Dehiscence Defects: A Dog Study Source.

Item does not contain fulltex

Osseointegration and stability of a modified sand-blasted acid-etched implant: An experimental pilot study in sheep

PubMedID: 20946211Objective: The aim of this pilot study was to compare the early-term osseointegration characteristics of standard (SLA) and modified sand-blasted and acid-etched (modSLA) implants in an experimental animal model. Material and methods: A total of 30 SLA and modSLA implants were placed to the tibiae of three sheep and the insertion torque value (ITV) and resonance frequency analysis (RFA) measurements were performed. RFA measurement was repeated on 3 and 6 weeks healed implants after which the animals were sacrificed for histomorphometric analysis. Bone-to-implant contact was assessed on the non-decalcified sections. Six weeks healed implants were also subjected to the reverse torque test (RTT). Results were analyzed by the Friedman test, Kruskal-Wallis test and Spearman rank correlation test. Results: All implants reached to a strong primary stability with a mean 36.13 ± 2.47 and 35.47 ± 2.85N/cm ITV. In the surgical stage, RFA values for SLA and modSLA implants were found to be 72.27 ± 3.17 and 71.6 ± 2.87, respectively. After 3 weeks of healing, mean BIC% (80.64 ± 13.89%) and RFA value (76.8 ± 1.14) of modSLA implants were significantly higher (P=0.0002) than that of SLA implants (64.39 ± 21.2 BIC% and 74.2 ± 4.76 RFA). However, no statistically significant difference between SLA and modSLA implants was recorded after 6 weeks of healing. Both implants revealed similar results in the RTT test (115.2 ± 4.14 and 117 ± 4.47N/cm for SLA and modSLA implants, respectively). No correlation was found between RFA and BIC%. Conclusion: Within the limits of this pilot study, it can be concluded that modSLA implants achieve a higher bone contact and stability at earlier time points when compared with SLA implants. © 2010 John Wiley & Sons A/S

Nitrideâ Coated Titanium Mesh and Particulate Allograft for Vertical Ridge Augmentation

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/141065/1/cap0182.pd